| Synovial Sarcoma studied in …STUDIED_INderived94 of 94show fewer |
|---|
| → studied in | NCT07174427Phase 3 · recruiting Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686367Phase 2 · not yet recruiting Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07613723Phase 1 · recruiting A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261657early Phase 1 · recruiting N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044768Phase 2 · active not recruiting Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05642455Phase 1/Phase 2 · recruiting SPEARHEAD-3 Pediatric Study · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617572available Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06083883Phase 1 · recruiting Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05227326Phase 1 · recruiting AOH1996 for the Treatment of Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713732Phase 1 · not yet recruiting TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02650986Phase 1/Phase 2 · active not recruiting Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625190Phase 1/Phase 2 · recruiting Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06571734Phase 2 · recruiting XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05910307recruiting Synovial Sarcoma Registry / Biospecimen Repository · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132922Phase 1 · active not recruiting MAGE-A4ᶜ¹º³²T for Multi-Tumor · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607692Phase 1/Phase 2 · recruiting Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05492682Phase 1 · recruiting START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06094101Phase 1/Phase 2 · recruiting Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483778Phase 1 · active not recruiting B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04420975Phase 1 · active not recruiting Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04008238NA · completed Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016819Phase 3 · recruiting Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432932recruiting Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169344Phase 2 · recruiting Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07173972Phase 2 · recruiting Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04995003Phase 1 · recruiting HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946225Phase 1 · recruiting ACTengine® IMA203 Combined With mRNA-4203 · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02869217Phase 1 · active not recruiting Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618381Phase 1 · active not recruiting EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875548Phase 1/Phase 2 · completed A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296564Phase 1/Phase 2 · recruiting Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277154Phase 2 · recruiting MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066982Phase 1/Phase 2 · recruiting Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601950Phase 2 · completed A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965753Phase 1 · terminated FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04537715Phase 1 · completed Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06456359Phase 2 · recruiting Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06748872Phase 1 · not yet recruiting EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05355753Phase 1 · terminated A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03250325Phase 1/Phase 2 · completed Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601937Phase 1 · completed EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604783Phase 1 · terminated Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526897NA · not yet recruiting Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670069Phase 1 · terminated Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04176016Phase 1 · terminated Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584309Phase 2 · completed Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03063632Phase 2 · completed Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03450122Phase 1 · completed Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145700Phase 1/Phase 2 · terminated CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03009201Phase 1 · completed Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399448Phase 1 · terminated NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00140855Phase 2 · terminated A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02601209Phase 1/Phase 2 · terminated Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00346164Phase 3 · completed Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02452554Phase 2 · completed Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma · condition mapped CURATED_BROADER · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05116800Phase 2 · withdrawn Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906876Phase 2 · withdrawn A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02181829Phase 2 · completed Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609984Phase 2 · terminated Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03520959Phase 3 · terminated A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702) · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03638206Phase 1/Phase 2 · unknown Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004853Phase 1 · completed Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02683148Phase 1 · terminated DHEA in Synovial Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01957709early Phase 1 · terminated Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03773510Phase 3 · withdrawn Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01614795Phase 2 · completed Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Childhood Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00668148Phase 2 · completed A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983539unknown Detection of Circulating Tumor Cells in Patients With Sarcomas · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112463Phase 2 · completed Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00356031Phase 2 · completed Bevacizumab and Radiation Therapy for Sarcomas · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469975Phase 1 · terminated First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10 · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01241162Phase 1 · completed Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02457650Phase 1 · unknown T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720174Phase 1 · completed Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567046completed Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Childhood Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059850Phase 1 · withdrawn NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674101NA · completed Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00837148Phase 2 · completed Sorafenib and Dacarbazine in Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030667Phase 2 · completed Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Childhood Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00831844Phase 2 · completed Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01477021Phase 1 · completed Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00331643Phase 2 · completed Ixabepilone in Treating Young Patients With Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01281865Phase 1/Phase 2 · completed Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503295Phase 2 · completed Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245102Phase 2 · completed Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · condition mapped ONTOLOGY_EXACT · 94 trials mapped (35 active) | — | — | Adult Synovial Sarcoma | 1 | Observed | clinicaltrials | graph → |